ndmain.gif (7669 bytes)800.926.2906
Anti-AgingSpecialsArticlesManufacturingFDA+pH WaterHiro
spc1.gif (174 bytes)VitaminsHerbsMineralsAminoAcidsEnzymesHormones
spc2.gif (174 bytes)HomeopathicsXtra-CellGlandularsFatty AcidsTop ProductsTop Products
Health Function Guide
Natural Medicines
Library
Dr Morrow
Physicians Only
Cal-Mag Chelate



 

Highly Bioavailable Calcium Magnesium Formula

 


Cal Mag Chelate
 

DESCRIPTION
Cal-Mag Chelate, provided by Nutrition Dynamics, Inc., is a special chelate complex of 6 sources of calcium with magnesium and other ingredients to assist the body in maintaining healthy bone structure. Calcium is a primary mineral for building the strong structure of bones and teeth.
 
FUNCTIONS
The adult human body contains approximately 1,200 g of calcium, about 99% of which is present in the skeleton, and 20-30 g of magnesium with about 60% located in bone. Bone is constantly turning over, a continuous process of formation and resorption. In children and adolescents, the rate of formation of bone mineral predominates over the rate of resorption. In later life, resorption predominates over formation. Therefore, in normal aging, there is a gradual loss of bone.
 
Intestinal calcium absorption ranges from 15 to 75% of ingested calcium. Vitamin D is a key regulatory hormone for calcium and bone metabolism. Adequate vitamin D status is essential for ensuring normal calcium absorption and maintenance of healthy calcium plasma levels. Magnesium absorption is independent of vitamin D status and ranges from 30 to 60% of ingested magnesium.
 
Osteoporosis, a condition of reduced bone mineral density that can increase risk of fractures, affects a large proportion of the elderly in developed countries. Caucasian and Asian women typically have low peak bone densities, and therefore, are at the greatest risk of developing osteoporosis. It is generally accepted that obtaining enough dietary calcium throughout life can significantly decrease the risk of developing osteoporosis. Among other factors, such as regular exercise, gender and race, calcium supplementation during childhood and adolescence appears to be a prerequisite for maintaining adequate bone density later in life. But even elderly osteoporotic patients can benefit significantly from supplementation with dietary calcium.
 
Cal-Mag Chelate provides a highly beneficial source of dietary calcium together with other nutrients that assist in the maintenance of healthy bone structure and function. For example, boron affects the composition, structure, and strength of bone. It appears to be necessary for calcium and magnesium absorption, their adequate renal reabsorption, and their incorporation into the bone matrix. Boron is absorbed at about 90% efficiency and is rapidly distributed among the tissues.
 
INDICATIONS
Cal-Mag Chelate may be a useful dietary supplement for those who wish to increase their intake of calcium and other nutritional factors for maintaining the function and structure of their bones.

FORMULA (#7015)

Three Tablets Contain:

Calcium (elemental)........................ 750. mg
Glutamic Acid HCl............................. 75. mg
Lysine HCl....................................... 36. mg
Boron (Aspartate/Citrate)................... 3. mg
Vitamin D-3................................... 400. I.U.
Magnesium (elemental).................. 375. mg
Vitamin C................................. ...... 50. mg

In a base of Silica

SUGGESTED USE
Adults take 1 tablet before each meal or as directed by physician.

SIDE EFFECTS
No adverse effects have been reported

HOW SUPPLIED
Supplied in bottles of 250 tablets.

STORAGE
Store in a cool, dry place, away from direct light. Keep out of reach of children.

References
Barger-Lux MJ, Heaney RP. The role of calcium intake in preventing bone fragility, hypertension, and certain cancers. J Nutr 1994;124:1406S-1411S.Bendich A, Leader S, Muhuri P. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits. Clin Ther 1999;21:1058-72.Bronner F. Calcium and osteoporosis. Am J Clin Nutr 1994;60:831-6.Bronner F, Pansu D. Nutritional aspects of calcium absorption. J Nutr 1999;129:9-12.Castelo-Branco C. Management of osteoporosis. An overview. Drugs Aging 1998;12:25-32.Celotti F, Bignamini A. Dietary calcium and mineral/vitamin supplementation: a controversial problem. J Int Med Res 1999;27:1-14.Chapin RE, Ku WW, Kenney MA, McCoy H, Gladen B, Wine RN, Wilson R, Elwell MR. The effects of dietary boron on bone strength in rats. Fundam Appl Toxicol 1997;35:205-15.Epstein O, Kato Y, Dick R, Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr 1982;36:426-30.Fleming KH, Heimbach JT. Consumption of calcium in the U.S.: food sources and intake levels. J Nutr 1994;124:1426S-1430S.Meacham SL, Taper LJ, Volpe SL. Effect of boron supplementation on blood and urinary calcium, magnesium, and phosphorus, and urinary boron in athletic and sedentary women. Am J Clin Nutr 1995;61:341-5.Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, Seeman E, Wasnich RD. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther 1999;21:1025-44.Nielsen FH. The justification for providing dietary guidance for the nutritional intake of boron. Biol Trace Elem Res 1998;66:319-30.O'Brien KO. Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women. Nutr Rev 1998;56:148-50.Patrick L. Comparative absorption of calcium sources and calcium citrate malate for the prevention of osteoporosis. Altern Med Rev 1999;4:74-85.Pines A, Raafat H, Lynn AH, Whittington J. Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy. Curr Med Res Opin 1984;8:734-42.Reid IR. The roles of calcium and vitamin D in the prevention of osteoporosis. Endocrinol Metab Clin North Am 1998;27:389-98.Sojka JE, Weaver CM. Magnesium supplementation and osteoporosis. Nutr Rev 1995;53:71-4.Stellon A, Davies A, Webb A, Williams R. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis. Postgrad Med J 1985;61:791-6.

 

These statements have not been evaluated by the Food and Drug Administration. .
This product is not intended to diagnose, treat, cure, or prevent any disease.
 
© 2008 Nutrition Dynamics, Inc. . All Rights Reserved
?
 






Site Navigation and Quick Links


Home • Health Club • Site Index • Library • Physicians Only • Checkout
Vitamins • Herbs • Minerals • Amino Acids • Enzymes • Hormones
Homeopathics • Ayurveda • Glandulars • Fatty Acids • Xtra-Cell

Alphabetical Product Index • Health Function Index • Condition Specific Formulas
The Latest Health Research • Prescription Drug Support Formulas

Frozen Cellular Extracts • Xtra-Cell • Top Products • New Products
Optimum Health Essentials™ • Ultra Preventive X

Contact Us • Customer Service • Privacy Policy • Conditions Of Use
Pricing, Availability and Returns • Privacy Companies

Development Team

Doctor Morrow
About Dr Morrow
Healing from Within
The Power of Prayer
Prayer Requests

Featured Products
Featured Product
Top Products
New Products

Optimum Health Essentials™

Ultra Preventive X

Ultra Preventive IX

Traumeel

Wobenzym N

Manufacturers
BHI
Douglas Laboratories
Heel
Metagenics
Nutrition Dynamics
Professional Health Products
Pure Encapsulations
Wobenzym

Checkout
Checkout
Physicians Checkout

Members
Member Zone

Physicians/Professionals/Affiliates
Signup
• Lost Password • Edit Profile


Nutrition Dynamics, Inc.• 510 West Court Street • Seguin, Texas 78155
Copyright © 1998-2008 • All Rights Reserved • Patent Pending
800.926.2906